NEOBACIN

This brand name is authorized in Albania, Nigeria.

Active ingredients

The drug NEOBACIN contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Neomycin UNII `I16QD7X297` - NEOMYCIN
	Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.
	Read more about Neomycin
`2`	Bacitracin UNII `89Y4M234ES` - BACITRACIN ZINC
	Read more about Bacitracin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D06AX04	Neomycin	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06A Antibiotics for topical use → D06AX Other antibiotics for topical use
Discover more medicines within D06AX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	92/105
NG	Registered Drug Product Database	04-5259
Switch country to Nigeria in order to find specific presentations of NEOBACIN

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.